/ EN
2025-10-09 00:00 JapanUnited States Policy & Regulation Regulatory Approval Translated from EN

Nihon Kohden's EEG-1260A Neurofax System Clears FDA 510(k)

Summary Nihon Kohden's EEG-1260A Neurofax system, along with its amplifier unit and photic stimulator, received FDA 510(k) clearance on October 9, 2025. The device is a Class II medical device in the neurology specialty, with software for quantitative EEG analysis. The traditional 510(k) clearance indicates substantial equivalence to a legally marketed device.
Why it matters Clinical EEG's incumbent vendors keep clearing quantitative-analysis software through the 510(k) route, setting the predicate ladder that newer neural-interface entrants will have to climb to reach the same hospital installed base.

BCIwiki (bciwiki.com) — Nihon Kohden's EEG-1260A Neurofax system, along with its JE-940A EEG Amplifier Unit and LS-940A Photic Stimulator, received FDA 510(k) clearance on October 9, 2025. The FDA decision, recorded as "substantially equivalent," was a traditional 510(k) clearance for a Class II device under the Neurology advisory committee, with regulation number 882.1400.

The device is classified under the name "Non-Normalizing Quantitative Electroencephalograph Software," indicating that its software functions include quantitative EEG analysis. The 510(k) clearance is a premarket notification pathway for moderate-risk devices, signifying that the device is substantially equivalent to a legally marketed predicate.

Compiled by BCIwiki from public sources

Sources · 1
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About